Franklin Resources
URGN icon

Franklin Resources’s UroGen Pharma URGN Stock Holding History

Franklin Resources’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$709K Buy
19,263
+2,518
+15% +$68.2K ﹤0.01% 2434
2026
Q1 		$301K Hold
16,745
– – ﹤0.01% 2664
2025
Q4 		$392K Buy
+16,745
New +$363K ﹤0.01% 2508

Other funds holding URGN

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Franklin Resources's URGN Position: Q2 2026 in Review

Franklin Resources increased its UroGen Pharma (URGN) stake by 15% in Q2 2026, buying an estimated $68.2K and bringing the position to 19,263 shares worth $709K. The position accounts for ﹤0.01% of the portfolio, ranked #2434.

Franklin Resources first reported a position in URGN in Q4 2025 and has held it in 3 quarters since. 189 funds tracked by Wall St. Rank hold URGN as of Q2 2026.

  • Franklin Resources held 19,263 shares of UroGen Pharma worth $709K as of Q2 2026.
  • Franklin Resources bought 2,518 UroGen Pharma shares in Q2 2026, an estimated $68.2K.
  • UroGen Pharma made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2434 holding.
  • Franklin Resources first reported a position in UroGen Pharma in Q4 2025 and has held it in 3 quarters since.
  • 189 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.